• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Next-generation Sequencing Identified a Novel WDPCP-ALK Fusion Sensitive to Crizotinib in Lung Adenocarcinoma.

作者信息

He Zhen, Wu Xuan, Ma Shuxiang, Zhang Cuicui, Zhang Zhe, Wang Shuai, Yu Sheng, Wang Qiming

机构信息

Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Clin Lung Cancer. 2019 Sep;20(5):e548-e551. doi: 10.1016/j.cllc.2019.06.001. Epub 2019 Jun 14.

DOI:10.1016/j.cllc.2019.06.001
PMID:31281052
Abstract
摘要

相似文献

1
Next-generation Sequencing Identified a Novel WDPCP-ALK Fusion Sensitive to Crizotinib in Lung Adenocarcinoma.下一代测序在肺腺癌中鉴定出一种对克唑替尼敏感的新型WDPCP-ALK融合基因。
Clin Lung Cancer. 2019 Sep;20(5):e548-e551. doi: 10.1016/j.cllc.2019.06.001. Epub 2019 Jun 14.
2
Coexistence of a Novel PRKCB-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient and Response to Crizotinib.一名肺腺癌患者中新型PRKCB-ALK、EML4-ALK双融合的共存及对克唑替尼的反应
J Thorac Oncol. 2019 Dec;14(12):e266-e268. doi: 10.1016/j.jtho.2019.07.021.
3
A novel HIP1-ALK fusion variant in lung adenocarcinoma showing resistance to Crizotinib.一种在肺腺癌中出现的对克唑替尼耐药的新型HIP1-ALK融合变体。
Lung Cancer. 2021 Jan;151:98-100. doi: 10.1016/j.lungcan.2020.11.014. Epub 2020 Nov 23.
4
The clinical responses of TNIP2-ALK fusion variants to crizotinib in ALK-rearranged lung adenocarcinoma.ALK 重排肺腺癌中 TNIP2-ALK 融合变体对克唑替尼的临床反应。
Lung Cancer. 2019 Nov;137:19-22. doi: 10.1016/j.lungcan.2019.08.032. Epub 2019 Aug 31.
5
Identification of a novel crizotinib-sensitive MET-ATXN7L1 gene fusion variant in lung adenocarcinoma by next generation sequencing.通过下一代测序在肺腺癌中鉴定出一种新型的对克唑替尼敏感的MET-ATXN7L1基因融合变体。
Ann Oncol. 2018 Dec 1;29(12):2392-2393. doi: 10.1093/annonc/mdy455.
6
A Novel Intergenic Region between CENPA and DPYSL5-ALK Exon 20 Fusion Variant Responding to Crizotinib Treatment in a Patient with Lung Adenocarcinoma.在一名肺腺癌患者中，CENPA与DPYSL5-ALK外显子20融合变体之间的一个新型基因间区域对克唑替尼治疗有反应。
J Thorac Oncol. 2019 Sep;14(9):e191-e193. doi: 10.1016/j.jtho.2019.04.012.
7
Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches.采用下一代测序方法检测肺癌患者中的已知和新型 ALK 融合转录本。
Sci Rep. 2017 Oct 2;7(1):12510. doi: 10.1038/s41598-017-12679-8.
8
Chr2 30297612-ALK, A Novel Intergenic Fusion With Exon18 of ALK, Responds to Crizotinib.Chr2 30297612-ALK，一种与ALK外显子18的新型基因间融合，对克唑替尼有反应。
Clin Lung Cancer. 2020 Nov;21(6):e564-e566. doi: 10.1016/j.cllc.2020.04.014. Epub 2020 May 6.
9
A novel SOS1-ALK fusion variant in a patient with metastatic lung adenocarcinoma and a remarkable response to crizotinib.一名转移性肺腺癌患者中存在新型 SOS1-ALK 融合变体，对克唑替尼有显著反应。
Lung Cancer. 2020 Apr;142:59-62. doi: 10.1016/j.lungcan.2020.02.012. Epub 2020 Feb 21.
10
Coexistence of a novel RGS18 downstream intergenic region ALK fusion and a THUMPD2-ALK fusion in a lung adenocarcinoma patient and response to crizotinib.一名肺腺癌患者中新型RGS18下游基因间区域ALK融合与THUMPD2-ALK融合的共存及对克唑替尼的反应
Lung Cancer. 2021 Apr;154:216-218. doi: 10.1016/j.lungcan.2021.02.008. Epub 2021 Feb 16.

引用本文的文献

1
Catalog of 5' Fusion Partners in -positive NSCLC Circa 2020.2020年左右阳性非小细胞肺癌中5'融合伙伴目录
JTO Clin Res Rep. 2020 Feb 19;1(1):100015. doi: 10.1016/j.jtocrr.2020.100015. eCollection 2020 Mar.
2
Interstitial Deletions Generating Fusion Genes.形成融合基因的染色体间片段缺失
Cancer Genomics Proteomics. 2021 May-Jun;18(3):167-196. doi: 10.21873/cgp.20251.
3
Pan-cancer investigation reveals mechanistic insights of planar cell polarity gene in carcinogenesis.泛癌症研究揭示平面细胞极性基因在肿瘤发生中的机制见解。
Aging (Albany NY). 2021 Feb 26;13(5):7259-7283. doi: 10.18632/aging.202582.
4
Coexistence of a novel CCNY-ALK and ATIC-ALK double-fusion in one patient with ALK-positive NSCLC and response to crizotinib: a case report.一名ALK阳性非小细胞肺癌患者中新型CCNY-ALK和ATIC-ALK双融合共存及对克唑替尼的反应：病例报告
Transl Lung Cancer Res. 2020 Dec;9(6):2494-2499. doi: 10.21037/tlcr-20-1049.
5
Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case report.通过下一代测序在晚期胆囊癌中鉴定出的新型AMBRA1-ALK融合对克唑替尼有反应：一例报告
Ann Transl Med. 2020 Sep;8(17):1099. doi: 10.21037/atm-20-1007.